Podcasts about md andersen

Podcast: LAS NOTICIAS CON CALLE DE 11 DE OCTUBRE DE 2023 - Buscan 220 mil empleados con el cambio de SNAP - Primera Hora - LUMA dice que han cumplido, que no se su culpa el atraso de energía renovable, que los fondos federales para desganche no se mueven por FEMA - El Vocero - Aumentan las compras cash de propiedades en PR - Aso. Realtors  - Salas de parto cerrando ante baja de natalidad - El Nuevo Día - Edwin Mundo a dirigir la campaña de Pierluisi - El Nuevo Día - Hoy se escoge el nuevo speaker del Congreso entre los republicanos - El Nuevo Día  - Empresas no quieren que pongan a pagar impuestos de propiedad a residencias exentas - El Nuevo Día - Sueltan a Eliezer Molina tras arrestarlo sin haber diligenciado antes la orden de acecho - Jay Fonseca app - DRNA negocia para demoler estructura en Sol y Playa - El Nuevo Día - Gobierno pide desestimar demanda por ubicación de fincas solares, dicen que plan de uso de terrenos no es obligatorio obedecer - El Vocero  - Graban intervención con fiscal que se negó a prueba de alcohol y que llegaron otros fiscales a cuestionar arresto - El Vocero  - Israel y Hamas en guerra, pero ahora se unió Hezbollah desde Líbano - CNBC - Exxon compra empresa de gas natural por 60 billones - Bloomberg  - El ejercicio reduce probabilidad de cáncer según estudio de MD Andersen  publicado en WebMD - Otra demanda entre Fahad y Paulson - El Nuevo Día En Liberty, el nuevo iPhone 15 Pro va por cuenta de Liberty.   No te pierdas el iPhone Pro más ligero de todos; con rendimiento a otro nivel; cámara angular; nuevo botón de acción; batería para todo el día; y muchísimo más.   Cámbiate hoy a Liberty y recibe $650 para el saldo del equipo con tu compañía actual.   Lleva tu número a la mejor red móvil en Puerto Rico.   Liberty. Tu mundo mejor conectado. Incluye auspicio

Our guest today is Dr. Christopher Logothetis, one of the nation's foremost experts on prostate cancer. Chris has spent nearly five decades at MD Anderson in Houston developing therapies for prostate cancer as well as conducting research into the underlying biology of the disease. Aside from skin cancers, prostate cancer is the most common cancer among men, claiming a man's life every 15 minutes in the United States, according to the Prostrate Cancer Foundation. Since the 1970s when Chris joined the staff at MD Andersen, which is the nation's top-ranked hospital for cancer care, he has been dedicated to the treatment, research, and prevention of genitourinary cancers such bladder, kidney, testes and penis cancer. For the past 25 years, he has focused primarily on prostate cancer and the development of effective chemotherapy treatments. Today, Chris is the director of MD Anderson's Genitourinary Cancer Center and the director of the Prostate Cancer Research Program. Show notes: [00:03:23] Dawn opens the interview mentioning that Chris went to medical school in Greece and asks if he grew up there as well. [00:03:43] Ken asks Chris when he first became interested in science. [00:04:09] Dawn asks if there were a particular teacher or class that prompted Chris' decision to pursue medicine. [00:04:39] Dawn asks what led Chris to attend the University of Athens School of Medicine. [00:05:10] Dawn mentions that in the ‘60s and ‘70s, talking about cancer was almost taboo and asks Chris to talk about the stigma that surrounded cancer for quite some time. [00:05:57] Ken asks if Chris knew he wanted to specialize in cancers when he first started medical school in Athens or if that interest developed later. [00:07:06] Dawn mentions that Chris graduated from medical school in 1974 and then took off for Chicago where he had an internship at Cook County Hospital. Dawn asks about the experience, and if it were a culture shock to go from Athens, Greece to Chicago in the 1970s. [00:08:54] Dawn asks what took Chris to Texas and MD Anderson after his time in Chicago. [00:09:36] Dawn mentions that after Chris finished his fellowship, he joined the faculty at MD Anderson, and is now coming upon his 50th anniversary there. [00:09:51] Chris explains his view that we need to better understand the drivers of cancer and goes on to talk about what we currently know about these drivers. [00:12:06] Ken asks about the significance of the Human Genome Project on cancer research. [00:13:49] Dawn mentions that along with new technologies, there evolved a strategy of what is called co-clinical investigation where researchers study the mouse, but in parallel look at the difference and similarities with humans. She asks him about how that integrated data required a new language to bring it all together, which is now known as Prometheus. Dawn asks Chris to talk about Prometheus and how this has led to an accelerated understanding of cancer biology. [00:20:47] Dawn mentions that Chris has studied a range of genitourinary cancers throughout his career, such as germ cell tumors, bladder, and renal cancers, but that his interest in prostate cancer is a more recent development. Dawn asks what led to this specific interest. [00:23:12] Dawn explains that metastatic cancer was first cured in 1956 when methotrexate was used to treat a rare tumor called choriocarcinoma. She goes on to say that since then, chemotherapy drugs have been used to treat mixed germ-cell tumors and has led to dramatically improved survivorship among patients with metastatic germ-cell tumors. She also mentions that in 1982 Chris published a paper in the journal Cancer titled, “The growing teratoma syndrome,” at which time, tumor growth following chemotherapy for mixed germ-cell tumors had been considered a reliable indicator of a persistent active carcinoma, with the rule being that if the cancer didn't respond to treatment that operations were fu...

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

Mind-Body Practices, Mind, Body, Spirit, Integrative Medicine, awareness,Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC, CancerWise, Qigong, Chi Gong

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

survivorship, cancer, patient education, patient, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

survivorship, cancer, patient education, patient, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

survivorship, cancer, patient education, patient, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

Cancer, md anderson, cancer center, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

ICARE, I*CARE, Communication, Interpersonal Communication, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC

Mind-Body Practices, Mind, Body, Spirit, Integrative Medicine, awareness,Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC, CancerWise, Qigong, Chi Gong

Mind-Body Practices, Mind, Body, Spirit, Integrative Medicine, awareness,Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC, CancerWise, Tai Chi, Tai Che

Mind-Body Practices, Mind, Body, Spirit, Integrative Medicine, awareness,Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC, CancerWise, Tai Chi, Tai Che

Melanoma, Ultraviolet, UV, Sunscreen, Sun Exposure, Skin Cancer, Cancer, oncology, MD Anderson, M.D. Anderson, MD Andersen, M.D. Andersen, M. D. Andersen, MDACC